Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Etheredge, US
Craig Etheredge, Ponte Vedra Beach, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20110191156 | PRE-APPROVED CUSTOMER ACCEPTANCE VALIDATION - In general, embodiments of the invention relate to systems, methods, and computer program products for producing a financial offer that is specific to a customer and storing the electronic acceptance and authentication of the acceptance in a digital medium. More particularly, embodiments of the invention relate to identifying a customer, providing a financial offer that is specific to that customer, and electronically storing both the authentication of the identity of the customer and the accompanying acceptance of the financial offer. | 08-04-2011 |
David Etheredge, New Port Richey, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20100205048 | System and Method for Media Monetization and Distribution - A system and method for media monetization and distribution, which includes at least a monetization engine, system and method, which includes at least one database of at least one media assets, at least one user defined mini-site utilizing at least one of the media assets, a recommendation engine that matches the mini-sites with at least one advertisement, and a delivery engine that integrates the at least one advertisement with the mini-site and allows for the monitoring of the integrated advertisement. | 08-12-2010 |
Larry Etheredge, Salinas, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080276546 | ADVANCED GUTTER SYSTEM - Disclosed herein is an advanced rain gutter system for preventing the blockage of a rain gutter system on a building roof. The system includes a shield having a first end zone adapted for connection to the roof and a second end zone which forms a curved shaped lip and the lip is in near touching contact with the gutter, substantially covering the gutter without doing so completely. | 11-13-2008 |
La Tia Etheredge, Tampa, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20110244570 | VOLUME EXCLUSION AGENT TO ENHANCE FORMATION OF EXTRACELLULAR MATRIX - A method of enhancing the formation of extracellular matrix in culture. Cells in culture secrete most of the collagen into the media as unprocessed procollagen, i.e., the cells do not convert procollagen to collagen. In contrast, normal extracellular matrix deposition involves procollagen processing to collagen, fibril assembly and deposition into the cell layer to form a collagenous extracellular matrix. The addition of certain growth factors and the addition of a thin layer of a certain volume exclusion agent on top of the cells dramatically enhances the conversion of procollagen to collagen and will increase the amount of collagen and extracellular matrix associated with the cells. This invention advances bioengineering of connective tissues for medical applications that require an extensive and functional extracellular matrix with high tensile strength such as those in the cornea stroma, skin, tendons, ligaments, articular cartilage and the intervertebral disks. | 10-06-2011 |
Robert Etheredge, Natick, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110066134 | Controlling Drug Transport and Current in Iontophoretic Onychomycosis Treatment - Pharmaceutical drugs and formulations suitable for iontophoresis thereof that provide enhanced iontophoretic delivery of an anti-fungal drug to at least one body surface, such as a nail, are described. Also described are pharmaceutical formulations suitable for iontophoresis comprising terbinafine and methods for administering terbinafine to a body surface via iontophoresis. When the drug source is introduced into the nail using a mask, terbinafine concentrations in peripheral areas of nail following iontophoretic treatment are less than drug concentrations directly under the mask. Further, differences in delivered drug concentrations is effectuated by creating drug delivery gradients. Drug can be delivered to dissimilar tissues based on different transfer efficiencies exhibited by the dissimilar tissues, resulting in higher percentage delivery in one tissue vs. another tissue. | 03-17-2011 |
Robert W. Etheredge, Natick, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20080262414 | SINGLE USE APPLICATOR CARTRIDGE FOR AN ELECTROKINETIC DELIVERY SYSTEM AND METHOD FOR SELF ADMINISTRATION OF MEDICAMENTS - An applicator cartridge for use with a device for electrokinetically delivering a medicament to a treatment site, the cartridge including: an applicator head including an active electrode, and a conductive path extending between a pair of electrical contacts, wherein the electrical contacts electrically engage respective contacts on the device when the cartridge is inserted into the device; a matrix support surface of said applicator head adjacent the active electrode; a matrix attached to the matrix support surface and in contact with the active electrode, the matrix having an exposed surface adapted to be applied to the treatment site; a medicament or a medicament and an electrically conductive carrier carried by said matrix; a removable lid covering the exposed surface of the matrix and sealed to the applicator head, the lid is conductively coupled to the applicator head and completes the conductive path on the applicator head, wherein removal of the lid breaks the conductive path. | 10-23-2008 |
| 20080312579 | METHOD AND SYSTEM FOR MITIGATING CURRENT CONCENTRATION IN ELECTROKINETIC DRUG DELIVERY - An electrokinetic apparatus to apply medicament to a treatment site of a mammalian user, the apparatus including: a segmented active electrode; a medicament matrix having one side abutting the segmented active electrode and another side adapted to contact a surface of skin over the treatment site, wherein the matrix includes at least one current direction barrier suppressing transverse current flow through the matrix. | 12-18-2008 |
| 20080312580 | CURRENT CONCENTRATION SYSTEM AND METHOD FOR ELECTROKINETIC DELIVERY OF MEDICAMENTS - An electrokinetic apparatus to apply medicament to a treatment site of a mammalian user, the apparatus including: a flux concentrator including an active electrode and a counter electrode adapted to be applied to the surface of a toenail or fingernail of the user, and a medicament matrix adjacent the active electrode and arranged to be sandwiched between the active electrode and nail. | 12-18-2008 |
| 20080319371 | METHOD AND SYSTEM FOR TREATING OF ONYCHOMYCOSIS WITH AN APPLICATOR HAVING A GEL MEDICAMENT LAYER - A method to electrokinetically deliver a medicament to a nail of a mammalian user including: forming a cast of the nail of the user wherein the cast is a reverse impression of the nail; applying a medicament matrix to the nail; sandwiching the medicament matrix between the cast and the nail; pressing the medicament matrix to the nail using the cast; applying electrical current to an electrical current path extending through the medicament matrix and the nail, and delivering medicament from the matrix into the nail by electrokinetic transporting the medicament along the current path. | 12-25-2008 |
| 20110071491 | Current Concentration System and Method for Electrokinetic Delivery of Medicaments - An electrokinetic apparatus to apply medicament to a treatment site of a mammalian user, the apparatus including: a flux concentrator including an active electrode and a counter electrode adapted to be applied to the surface of a toenail or fingernail of the user, and a medicament matrix adjacent the active electrode and arranged to be sandwiched between the active electrode and nail. | 03-24-2011 |
William Craig Etheredge, Ponte Vedra Beach, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20080306848 | Lead Generation Platform - A method and system is disclosed for a financial institution to offer one or more financial products or services to a customer. Upon receiving a triggering event, such as a customer transaction, at least one of an internal and external database concerning is queried, and an algorithmic determination of an optimum selection of financial products to be offered to the customer is executed. The initiated financial transaction may be executed simultaneously with the determination of an optimum selection of financial products. The optimum selection of financial products and services may be offered by the financial institution employee who is also processing the customer transaction. | 12-11-2008 |